Premium
Serendipitous crystallization and structure determination of bacterioferritin from Achromobacter
Author(s) -
Dwivedy Abhisek,
Jha Bhavya,
Singh Khundrakpam Herojit,
Ahmad Mohammed,
Ashraf Anam,
Kumar Deepak,
Biswal Bichitra Kumar
Publication year - 2018
Publication title -
acta crystallographica section f
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 37
ISSN - 2053-230X
DOI - 10.1107/s2053230x18009809
Subject(s) - chemistry , crystallography , porphyrin , moiety , dimer , achromobacter , heme , crystallization , ferritin , stereochemistry , photochemistry , biochemistry , bacteria , biology , organic chemistry , pseudomonas , genetics , enzyme
Bacterioferritins (Bfrs) are ferritin‐like molecules with a hollow spherical 24‐mer complex design that are unique to bacterial and archaeal species. They play a critical role in storing iron(III) within the complex at concentrations much higher than the feasible solubility limits of iron(III), thus maintaining iron homeostasis within cells. Here, the crystal structure of bacterioferritin from Achromobacter ( Ach Bfr) that crystallized serendipitously during a crystallization attempt of an unrelated mycobacterial protein is reported at 1.95 Å resolution. Notably, Fe atoms were bound to the structure along with a porphyrin ring sandwiched between the subunits of a dimer. Furthermore, the dinuclear ferroxidase center of Ach Bfr has only a single iron bound, in contrast to the two Fe atoms in other Bfrs. The structure of Ach Bfr clearly demonstrates the substitution of a glutamate residue, which is involved in the interaction with the second Fe atom, by a threonine and the consequent absence of another Fe atom there. The iron at the dinuclear center has a tetravalent coordination, while a second iron with a hexavalent coordination was found within the porphyrin ring, generating a heme moiety. Achromobacter spp. are known opportunistic pathogens; this structure enhances the current understanding of their iron metabolism and regulation, and importantly will be useful in the design of small‐molecule inhibitors against this protein through a structure‐guided approach.